Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideyuki Harada

Showing results (71-80 of 160) with videos related to

Pageof 16
Sort By:
Journal of Radiation Research|October 10, 2017
Fracture after radiation therapy for femoral metastasis: incidence, timing and clinical featuresTetsuo Shimoyama, Hirohisa Katagiri, Hideyuki Harada, et al.
International Journal of Radiation Oncology, Biology, Physics|April 27, 2010
Radiotherapy for patients with metastases to the spinal column: a review of 603 patients at Shizuoka Cancer Center HospitalMasashi Mizumoto, Hideyuki Harada, Hirofumi Asakura, et al.
BMC Cancer|April 19, 2020
Retrospective analysis of salvage surgery for local progression of brain metastasis previously treated with stereotactic irradiation: diagnostic contribution, functional outcome, and prognostic factorsKoichi Mitsuya, Yoko Nakasu, Nakamasa Hayashi, et al.
World Neurosurgery|September 11, 2022
Endoscopic Trans-Mini-Cylinder Biopsy for Intraparenchymal Brain LesionsKazuhito Takeuchi, Fumiharu Ohka, Yuichi Nagata, et al.
Cancer Science|January 11, 2016
Feasibility study of chemoradiotherapy followed by amrubicin and cisplatin for limited-disease small cell lung cancerIkuo Sekine, Minako Sumi, Miyako Satouchi, et al.
Clinical Lung Cancer|September 30, 2018
A Phase II Study of Gefitinib With Concurrent Thoracic Radiotherapy in Patients With Unresectable, Stage III Non-small-cell Lung Cancer Harboring EGFR Mutations (WJOG6911L)Hiroaki Akamatsu, Hideyuki Harada, Shoji Tokunaga, et al.
Japanese Journal of Clinical Oncology|March 17, 2021
A multi-institutional randomized phase III study comparing weekly carboplatin plus nab-paclitaxel and daily low-dose carboplatin as regimens for concurrent chemoradiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1914Ryo Shimoyama, Shota Omori, Shogo Nomura, et al.
Anticancer Research|December 27, 2011
Continuous administration of EGFR-TKIs following radiotherapy after disease progression in bone lesions for non-small cell lung cancerMinehiko Inomata, Takehito Shukuya, Toshiaki Takahashi, et al.
International Journal of Clinical Oncology|May 4, 2017
Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1)Tomoki Kimura, Yasushi Nagata, Hideyuki Harada, et al.
International Journal of Clinical Oncology|December 8, 2009
Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancerHideyuki Harada, Nobuyuki Yamamoto, Toshiaki Takahashi, et al.
Pageof 16

Showing results (71-80 of 160) with videos related to

Sort By:
Pageof 16
Journal of Radiation Research|October 10, 2017
Fracture after radiation therapy for femoral metastasis: incidence, timing and clinical featuresTetsuo Shimoyama, Hirohisa Katagiri, Hideyuki Harada, et al.
International Journal of Radiation Oncology, Biology, Physics|April 27, 2010
Radiotherapy for patients with metastases to the spinal column: a review of 603 patients at Shizuoka Cancer Center HospitalMasashi Mizumoto, Hideyuki Harada, Hirofumi Asakura, et al.
BMC Cancer|April 19, 2020
Retrospective analysis of salvage surgery for local progression of brain metastasis previously treated with stereotactic irradiation: diagnostic contribution, functional outcome, and prognostic factorsKoichi Mitsuya, Yoko Nakasu, Nakamasa Hayashi, et al.
World Neurosurgery|September 11, 2022
Endoscopic Trans-Mini-Cylinder Biopsy for Intraparenchymal Brain LesionsKazuhito Takeuchi, Fumiharu Ohka, Yuichi Nagata, et al.
Cancer Science|January 11, 2016
Feasibility study of chemoradiotherapy followed by amrubicin and cisplatin for limited-disease small cell lung cancerIkuo Sekine, Minako Sumi, Miyako Satouchi, et al.
Clinical Lung Cancer|September 30, 2018
A Phase II Study of Gefitinib With Concurrent Thoracic Radiotherapy in Patients With Unresectable, Stage III Non-small-cell Lung Cancer Harboring EGFR Mutations (WJOG6911L)Hiroaki Akamatsu, Hideyuki Harada, Shoji Tokunaga, et al.
Japanese Journal of Clinical Oncology|March 17, 2021
A multi-institutional randomized phase III study comparing weekly carboplatin plus nab-paclitaxel and daily low-dose carboplatin as regimens for concurrent chemoradiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1914Ryo Shimoyama, Shota Omori, Shogo Nomura, et al.
Anticancer Research|December 27, 2011
Continuous administration of EGFR-TKIs following radiotherapy after disease progression in bone lesions for non-small cell lung cancerMinehiko Inomata, Takehito Shukuya, Toshiaki Takahashi, et al.
International Journal of Clinical Oncology|May 4, 2017
Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1)Tomoki Kimura, Yasushi Nagata, Hideyuki Harada, et al.
International Journal of Clinical Oncology|December 8, 2009
Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancerHideyuki Harada, Nobuyuki Yamamoto, Toshiaki Takahashi, et al.
Pageof 16